Allstate Corp. closed 8.24% short of its 52-week high of $213.18, which the company achieved on June 3rd.

Analysts have set 12-month price targets for Allstate, revealing an average target of $216.88, a high estimate of $250.00, ...

Allstate Corporation ended 2024 on a high note, reporting strong financial and strategic performance in the fourth quarter and full year. The company posted $16.5 billion in total revenue for Q4 ...

Allstate offers strong yields on preferreds and bonds, backed by solid ratings and insurer strength despite weather losses.

Allstate Corp. closed 7.97% below its 52-week high of $213.18, which the company reached on June 3rd.

Morgan Stanley analyst Bob Huang has maintained their bullish stance on ALL stock, giving a Buy rating on October 18. Bob Huang has given his B ...

The Allstate Corporation ALL recently closed the sale of its Group Health business to Nationwide for a total consideration of $1.25 billion. ALL initially announced its intention to divest this ...

This adjustment was based on Allstate's recent financial performance and strategic initiatives, with the firm projecting a modest increase in earnings per share estimates for 2026 and 2027.

Nevertheless, Allstate’s overall performance has remained more than impressive. The company reported a staggering 14.7% year-over-year growth in consolidated revenues to $16.6 billion.

For valuable insights into Allstate's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings ...

BMO maintains Allstate stock Outperform rating, $222 target ...